Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage, for any covered stock.
TapClick below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
TapClick below to see what's inside, then upgrade to unlock for SHTDF and 80,000+ other tickers.
See price against where its own fundamentals say it should trade. The shaded gap is the discount or premium, across five valuation lenses.
TapClick below to see what's inside, then upgrade to unlock for SHTDF and 80,000+ other tickers.
See exactly how SHTDF's revenue becomes profit: a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for SHTDF and 80,000+ other tickers.
Sinopharm Group Co. Ltd., along with its affiliates, plays a significant role in the People's Republic of China's healthcare sector, primarily engaging in the wholesale and retail trade of pharmaceuticals, medical equipment, and health-related products. The company organizes its extensive operations across four distinct divisions. Its Pharmaceutical Distribution unit supplies a wide array of medicinal products to various clients, including hospitals, other distributors, retail pharmacies, and clinics. This segment also provides comprehensive distribution, logistics, and additional value-added…
Sinopharm Group Co. Ltd. (OTCMKTS:SHTDF - Get Free Report) shares passed below its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $2.42 and traded as low as $2.35. Sinopharm Group shares last traded at $2.35, with a volume of 0 shares traded. Sinopharm Group Price Performance The
Sinopharm Group Co. Ltd. (OTCMKTS:SHTDF - Get Free Report)'s share price passed above its 50-day moving average during trading on Monday. The stock has a 50-day moving average of $2.53 and traded as high as $2.60. Sinopharm Group shares last traded at $2.4750, with a volume of 600 shares traded. Sinopharm Group Stock Performance